Vadodara: In a major boost for cancer treatment and drug stability, researchers have developed a new freeze-dried formulation that can significantly extend the shelf life and post-reconstitution stability of key…
New Delhi: One of the most closely watched controversies in India's pharmaceutical sector last year, surrounding the continuation of the Drugs Controller General of India (DCGI) beyond retirement, has been…
India: A new randomized clinical trial from the All India Institute of Medical Sciences (AIIMS), New Delhi, has reported encouraging results on the use of tenecteplase for treating obstructive mechanical…
A new study published in the BMJ Heart showed that in infective endocarditis (IE) surgery, anemia and transfusion are quite common and linked to higher mortality. Despite improvements in treatment,…
The U.S. Food and Drug Administration has approved the Zycubo (copper histidinate) injection as the first treatment for Menkes disease in pediatric patients. “With today’s action, children with this devastating,…
A hormone produced in the thyroid gland can play a key role in the development of prostate cancer. This is shown in a new study by an international research group…
The TOGETHER-PsA study shows that combining ixekizumab with tirzepatide leads to significantly better psoriatic arthritis disease control and greater weight reduction compared with ixekizumab alone in patients with PsA and…
Rajkot: A Haryana-based pharmaceutical company, Alps Life Sciences Pvt. Ltd., along with three of its senior officials, has been convicted and sentenced to seven years of rigorous imprisonment for the…
In a phase three, double blind, placebo controlled trial, pegcetacoplan significantly reduced proteinuria compared with placebo in patients with recurrent C3 glomerulopathy or primary immune complex membranoproliferative glomerulonephritis, highlighting its…
A veteran FDA regulator who left last month said the firewall between agency political appointees and drug reviewers “has been breached"